semaglutide black market Thrives as Appetite Control Demand Outpaces Regulation | Molekule Consulting posted on the topic TOMORROW: A CNBC investigation finds

Oral GLP-1 medications may be a reasonable option for: Patients early in their weight loss journey Patients with mild to moderate weight loss goals Patients who strongly prefer to avoid injections They may be less ideal for: Patients who have had bariatric surgery Patients needing significant weight loss Patients who have not responded to oral medications in the past The decision is not just about preference

However, BMI is not a one-size-fits-all measurement

While both are injectable peptides used in precision medicine, they function through entirely different biological mechanisms

Based on current clinical trial data, yes